Literature DB >> 20359617

[Lyell's syndrome occurring in three HIV-positive patients undergoing anti-tuberculous therapy].

B Kouassi1, K Horo, B Vilasco, N Koffi, Y Kouamé, B Ahui, C Gode, A N'Gom, E Aka-Danguy, M Tchramran, A Kamagaté.   

Abstract

We describe three cases of Lyell syndrome - toxic epidermal necrolysis - occurring in patients under the respiratory service of CHU de Cocody in Abidjan in the Ivory Coast, who were undergoing anti-tuberculous (TB) chemotherapy. All three were adult males who were HIV-positive, but none of them were receiving anti-retroviral treatment. They were on standard anti-TB treatment; rifampicin, isoniazid, pyazinamide and ethambutol. The lesions appeared early during their treatment for TB (14, 20 and 45 days). The patients were on no other medication that might have caused Lyell's syndrome except one who had been on cotrimoxasole for 6 months without complications. Despite admission to the acute care facility and appropriate care two of the three patients died. Copyright 2010. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359617     DOI: 10.1016/j.rmr.2010.01.010

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  1 in total

1.  Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, Cameroon.

Authors:  Emmanuel Armand Kouotou; Jobert Richie Nansseu; Vanessa Nancy Ngono; Sandra A Tatah; Anne Cecile Zoung-Kanyi Bissek; Elie Claude Ndjitoyap Ndam
Journal:  Dermatol Res Pract       Date:  2017-06-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.